Log in to save to my catalogue

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1792373955

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a randomized, multicenter trial involving boys with severe hemophilia A, the incidence of neutralizing antibodies to factor VIII was 87% higher with recombinant factor VIII products than with plasma-derived factor VIII products.
Hemophilia A is an inherited bleeding disorder characterized by plasma deficiency of coagulation factor VIII.
1<...

Alternative Titles

Full title

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1792373955

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1792373955

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1516437

How to access this item